Community post

The ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) Network is offering funding for Phase II or III clinical trials focusing on antimicrobial agents for multi-resistant Gram-negative bacilli infections. Application deadline is March 15.